相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。The future of research in hematology: Integration of conventional studies with real-world data and artificial intelligence
Francesco Passamonti et al.
BLOOD REVIEWS (2022)
TET2 mutations as a part of DNA dioxygenase deficiency in myelodysplastic syndromes
Carmelo Gurnari et al.
BLOOD ADVANCES (2022)
A cellular hierarchy framework for understanding heterogeneity and predicting drug response in acute myeloid leukemia
Andy G. X. Zeng et al.
NATURE MEDICINE (2022)
Pathophysiologic and clinical implications of molecular profiles resultant from deletion 5q
Vera Adema et al.
EBIOMEDICINE (2022)
Individual HLA heterogeneity and its implications for cellular immune evasion in cancer and beyond
Simona Pagliuca et al.
FRONTIERS IN IMMUNOLOGY (2022)
Complex landscape of alternative splicing in myeloid neoplasms
Courtney E. Hershberger et al.
LEUKEMIA (2021)
Classification and Personalized Prognostic Assessment on the Basis of Clinical and Genomic Features in Myelodysplastic Syndromes
Matteo Bersanelli et al.
JOURNAL OF CLINICAL ONCOLOGY (2021)
Fast and precise single-cell data analysis using a hierarchical autoencoder
Duc Tran et al.
NATURE COMMUNICATIONS (2021)
Have we reached a molecular era in myelodysplastic syndromes?
Maria Teresa Voso et al.
HEMATOLOGY-AMERICAN SOCIETY OF HEMATOLOGY EDUCATION PROGRAM (2021)
A geno-clinical decision model for the diagnosis of myelodysplastic syndromes
Nathan Radakovich et al.
BLOOD ADVANCES (2021)
Machine Learning Integrates Genomic Signatures for Subclassification Beyond Primary and Secondary Acute Myeloid Leukemia
Hassan Awada et al.
BLOOD (2021)
How artificial intelligence might disrupt diagnostics in hematology in the near future
Wencke Walter et al.
ONCOGENE (2021)
Machine Learning of Bone Marrow Histopathology Identifies Genetic and Clinical Determinants in Patients with MDS
Oscar E. Bruck et al.
BLOOD CANCER DISCOVERY (2021)
Functional and conformational impact of cancer-associated SF3B1 mutations depends on the position and the charge of amino acid substitution
Christine Canbezdi et al.
COMPUTATIONAL AND STRUCTURAL BIOTECHNOLOGY JOURNAL (2021)
A deep adversarial variational autoencoder model for dimensionality reduction in single-cell RNA sequencing analysis
Eugene Lin et al.
BMC BIOINFORMATICS (2020)
Integrating the Immunome in the Stratification of Myelodysplastic Syndromes and Future Clinical Trial Design
Susann Winter et al.
JOURNAL OF CLINICAL ONCOLOGY (2020)
Luspatercept in Patients with Lower-Risk Myelodysplastic Syndromes
Pierre Fenaux et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Interpretable factor models of single-cell RNA-seq via variational autoencoders
Valentine Svensson et al.
BIOINFORMATICS (2020)
Mutations in the RNA Splicing Factor SF3B1 Promote Tumorigenesis through MYC Stabilization
Zhaoqi Liu et al.
CANCER DISCOVERY (2020)
Machine learning demonstrates that somatic mutations imprint invariant morphologic features in myelodysplastic syndromes
Yasunobu Nagata et al.
BLOOD (2020)
Hotspot SF3B1 mutations induce metabolic reprogramming and vulnerability to serine deprivation
W. Brian Dalton et al.
JOURNAL OF CLINICAL INVESTIGATION (2019)
Digital twins to personalize medicine
Bergthor Bjornsson et al.
GENOME MEDICINE (2019)
Impact of spliceosome mutations on RNA splicing in myelodysplasia: dysregulated genes/pathways and clinical associations
Andrea Pellagatti et al.
BLOOD (2018)
Aberrant splicing and defective mRNA production induced by somatic spliceosome mutations in myelodysplasia
Yusuke Shiozawa et al.
NATURE COMMUNICATIONS (2018)
Immune Escape of Relapsed AML Cells after Allogeneic Transplantation
M. J. Christopher et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
The U2AF1S34F mutation induces lineage-specific splicing alterations in myelodysplastic syndromes
Bon Ham Yip et al.
JOURNAL OF CLINICAL INVESTIGATION (2017)
Cryptic splicing events in the iron transporter ABCB7 and other key target genes in SF3B1-mutant myelodysplastic syndromes
H. Dolatshad et al.
LEUKEMIA (2016)
U2AF35(S34F) Promotes Transformation by Directing Aberrant ATG7 Pre-mRNA 3′ End Formation
Sung Mi Park et al.
MOLECULAR CELL (2016)
Cancer-associated SF3B1 mutations affect alternative splicing by promoting alternative branchpoint usage
Samar Alsafadi et al.
NATURE COMMUNICATIONS (2016)
Aberrant splicing of genes involved in haemoglobin synthesis and impaired terminal erythroid maturation in SF3B1 mutated refractory anaemia with ring sideroblasts
Simona Conte et al.
BRITISH JOURNAL OF HAEMATOLOGY (2015)
SRSF2 Mutations Contribute to Myelodysplasia by Mutant-Specific Effects on Exon Recognition
Eunhee Kim et al.
CANCER CELL (2015)
Mutant U2AF1 Expression Alters Hematopoiesis and Pre-mRNA Splicing In Vivo
Cara Lunn Shirai et al.
CANCER CELL (2015)
Disruption of SF3B1 results in deregulated expression and splicing of key genes and pathways in myelodysplastic syndrome hematopoietic stem and progenitor cells (vol 29, pg 1092, 2015)
H. Dolatshad et al.
LEUKEMIA (2015)
limma powers differential expression analyses for RNA-sequencing and microarray studies
Matthew E. Ritchie et al.
NUCLEIC ACIDS RESEARCH (2015)
Deregulation of Genes Related to Iron and Mitochondrial Metabolism in Refractory Anemia with Ring Sideroblasts
Monica del Rey et al.
PLOS ONE (2015)
Distinct iron architecture in SF3B1-mutant myelodysplastic syndrome patients is linked to an SLC25A37 splice variant with a retained intron
V. Visconte et al.
LEUKEMIA (2015)
PRPF8 defects cause missplicing in myeloid malignancies
A. Kurtovic-Kozaric et al.
LEUKEMIA (2015)
Model-based clustering of high-dimensional data: A review
Charles Bouveyron et al.
COMPUTATIONAL STATISTICS & DATA ANALYSIS (2014)
Molecular signatures database (MSigDB) 3.0
Arthur Liberzon et al.
BIOINFORMATICS (2011)
Changes in RPS14 expression levels during lenalidomide treatment in Low- and Intermediate-1-risk myelodysplastic syndromes with chromosome 5q deletion
Esther N. Oliva et al.
EUROPEAN JOURNAL OF HAEMATOLOGY (2010)
Transcript assembly and quantification by RNA-Seq reveals unannotated transcripts and isoform switching during cell differentiation
Cole Trapnell et al.
NATURE BIOTECHNOLOGY (2010)
Low RPS14 expression is common in myelodysplastic syndromes without 5q-aberration and defines a subgroup of patients with prolonged survival
Akos Czibere et al.
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL (2009)
Identification of RPS14 as a 5q- syndrome gene by RNA interference screen
Benjamin L. Ebert et al.
NATURE (2008)
Lenalidomide in the myelodysplastic syndrome with chromosome 5q deletion
Alan List et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)